Institute for Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
The Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria.
Biochem Soc Trans. 2022 Apr 29;50(2):813-824. doi: 10.1042/BST20211186.
The death fold domain-containing protein PIDD1 has recently attracted renewed attention as a regulator of the orphan cell death-related protease, Caspase-2. Caspase-2 can activate p53 to promote cell cycle arrest in response to centrosome aberrations, and its activation requires formation of the PIDDosome multi-protein complex containing multimers of PIDD1 and the adapter RAIDD/CRADD at its core. However, PIDD1 appears to be able to engage with multiple client proteins to promote an even broader range of biological responses, such as NF-κB activation, translesion DNA synthesis or cell death. PIDD1 shows features of inteins, a class of self-cleaving proteins, to create different polypeptides from a common precursor protein that allow it to serve these diverse functions. This review summarizes structural information and molecular features as well as recent experimental advances that highlight the potential pathophysiological roles of this unique death fold protein to highlight its drug-target potential.
死亡折叠域包含蛋白 PIDD1 最近作为孤儿细胞死亡相关蛋白酶 Caspase-2 的调节剂重新引起了人们的关注。Caspase-2 可以激活 p53,以响应中心体异常来促进细胞周期停滞,其激活需要形成包含 PIDD1 多聚体和衔接子 RAIDD/CRADD 的 PIDDosome 多蛋白复合物作为核心。然而,PIDD1 似乎能够与多种客户蛋白结合,以促进更广泛的生物学反应,如 NF-κB 激活、跨损伤 DNA 合成或细胞死亡。PIDD1 具有整合酶的特征,整合酶是一类自我切割的蛋白质,它从共同的前体蛋白中产生不同的多肽,从而使其能够发挥这些不同的功能。这篇综述总结了结构信息和分子特征,以及最近的实验进展,这些进展强调了这种独特的死亡折叠蛋白的潜在病理生理作用,突出了其作为药物靶点的潜力。